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1. Introduction 
The relationship between nutrition and immune function is being widely recognized, 
although its study is relatively recent. The 1968 World Health Organisation monograph about 
“Interactions between Nutrition and Infection” presented the mechanisms linking infection 
and poor nutritional status. Following the development of immunology as a science, 
increasing evidence was obtained as well to show how undernutrition impaired resistance 
to infections and the immune response. It was initially recognized that deficits in certain 
micronutrients (like vitamins and minerals) had a direct impact on immune function. But 
the relationship between immune function and nutrition extends far beyond that, and the 
term immunonutrition has been coined. We are now aware of many conditions of 
nutritional imbalance (not all necessarily linked to nutritional deficiencies) that lead to 
impaired immune response. For instance, it is currently believed that nutrition is a key 
factor in the onset and development of many types of cancer, or that the dietary component 
of atherosclerosis risk can directly influence immune cells and the inflammatory response; 
certain nutrients, like seed and fish oils have been shown to respectively induce the release 
of pro- and anti-inflammatory mediators. Accordingly, the idea of undernutrition has been 
replaced by that of malnutrition, meaning that inappropriate nutrition or nutritional 
imbalance per se, whether it implies a nutrient deficit or not, influences immune function. 
That is the reason why overnutrition, or an excessive energy intake, is also now considered 
as malnutrition. 
In this chapter we will discuss three paradigmatic cases of malnutrition that have a strong 
immune and inflammatory impact: anorexia nervosa (AN) and bulimia nervosa (BN), as 
examples of severe undernutrition; obesity, also referred to as overnutrition; and celiac 
disease (CD), a pathological reaction of the body to a particular type of nutrients that leads 
to malnutrition. Although these nutrition-related diseases have different origins 
(psychological for eating disorders, modifiable lifestyle factors for obesity and autoimmune 
for CD), they all have in common to present an important inflammatory component and to 
have nutritional treatment as the main therapeutic approach. 
2. Eating disorders 
Anorexia nervosa (AN) and bulimia nervosa (BN) are states of malnutrition of psychiatric 
origin. Although conventionally AN has been described among adolescents, the prevalence 
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of this syndrome is now increasing in prepubertal girls. Since AN starts at very early stages 
of life, and often implies a chronic and disabling course, severe consequences on somatic 
and mental health may be developed in adulthood (Marcos et al., 2003). Besides a reduced 
growth, diminished reproduction rate and an increased risk of osteoporosis, a prolonged 
course of the disorder may impact on the development of the anorexic patients’ brain 
function, probably due to hormonal dysfunctions coming from the corticoid and gonadal 
systems, and to severe changes in neuropeptides, all these alterations promoting hence 
disturbance of the immune system of these patients (Table 1). 
 
Biomarker Alteration Reference 
Adiponectin Increased Leoni et al., 2010 
CD4+:CD8+ Decreased Marcos et al., 1993 
C3 (complement) Decreased Flierl et al., 2011 
Ghrelin Increased Terashi, 2011 
IL-1 Increased Allende et al., 1998 
IL-6 Increased Nova & Marcos, 2006 
Lymphocytes Decreased Marcos et al., 1993 
Resistin Decreased Leoni et al., 2010 
TNF-ǂ Increased Nova & Marcos, 2006 
Table 1. Inflammation-related blood biomarkers altered in eating disorders 
Despite the seriously malnourished state of patients with AN and BN, controversial findings 
have been published regarding some aspects of the immune system that are otherwise 
impaired in more typical types of malnutrition, such as protein-energy malnutrition (Nova 
& Marcos, 2006). In this respect, it should be noted that recent neurobiological insights into 
this gut-brain crosstalk have revealed a complex, bidirectional communication system that 
not only ensures the proper maintenance of gastrointestinal homeostasis and digestion but 
is likely to have multiple effects on affect, motivation and higher cognitive functions, 
including intuitive decision making. Moreover, disturbances of this system have been 
involved in a wide range of disorders, including functional and inflammatory 
gastrointestinal disorders, obesity and eating disorders (Mayer, 2011). 
2.1 Altered immunity in eating disorders 
Anemia, leukopenia and thrombocytopenia are frequent complications of AN (Cleary et al., 
2010) together with relative lymphocytosis (Marcos et al., 1993). Anemia tends to be 
normocytic and normochromic. Leukopenia manifests as a deficiency of lymphocytes or 
neutrophils. Thrombocytopenia, if severe, may confer a bleeding risk. However, cell-
mediated immunity is usually altered in AN and BN as reflected by lymphocyte subset 
counts and the response to delayed hypersensitivity tests. Regarding the helper/cytotoxic T 
cell ratio (CD4+:CD8+), an immunological marker of the nutritional status, the results of our 
studies on AN and BN patients showed that the duration of the eating disorder and the time 
when appropriate treatment is achieved are likely contributors to the alteration of this ratio. 
Immune-competent cell line deficiencies related solely to AN often resolve with nutritional 
rehabilitation. 
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The association between lymphocyte subsets and several psychopathological variables 
which had proved to be able to affect immune cell count in other conditions was 
investigated in BN patients. A negative correlation between impulsivity and T helper cells 
(CD4+) was found in controls. In the BN group, the patients with higher anxiety had the 
lower lymphocyte count, and anxiety and hostility were negatively related to CD4+ count. In 
addition, helper/cytotoxic T cell ratio negatively correlated in this group with impulsivity, 
hostility, and depression. In the light of these results, the potential influence of 
psychopathology on lymphocyte subset counts seems to be specific in BN patients, and 
more relevant than in healthy controls (Vaz-Leal et al., 2010). 
Moreover, the complement cascade, a major component of innate immunity, represents a 
driving force in the pathophysiology of multiple inflammatory disorders. The role of 
complement in AN remains poorly understood. Serum C3 levels were significantly lower in 
patients with AN than in controls. There was a strong correlation between index C3 levels 
and BMI. Therefore, the C3 complement factor serum levels may represent a sensitive new 
biomarker for monitoring the severity of disease in AN (Flierl et al., 2011). 
2.2 Relationship between eating disorders and the neuroendocrine/immune systems 
Immune impairments in AN are less severe than would be expected considering the highly 
deficient nutritional status of these patients, and also, they seem to be surprisingly free of 
infectious complications or even common viral infections, at least until the most advanced 
stages of debilitation (Marcos, 2000). Hypothetically, some of the complex interactions 
occurring between cytokines and the endocrine system and the central nervous system 
could provide some compensatory mechanisms to adapt to the limited nutrient supply and 
possibly result in the perceived lack of infection symptoms. A dysregulated cytokine 
production and the altered acute-phase response to infection, as well as cortisol and leptin, 
are considered to be potential factors involved in the adaptation processes occurring in these 
syndromes (Nova et al., 2002). 
Productions of cytokines [interferon (IFN)-Ǆ, interleukin (IL)-2, tumor necrosis factor (TNF)-
ǂ, IL-6, and IL-1ǃ] involved in the regulation of the immune response are dysregulated in 
AN patients. In the context of inflammation, pro-inflammatory cytokines can access the 
central nervous system and interact with a cytokine network in the brain to influence 
virtually every aspect of brain function relevant to behaviour, including neurotransmitter 
metabolism, neuroendocrine function, synaptic plasticity, and neurocircuits that regulate 
mood, motor activity, motivation, anxiety, and alarm. 
TNF-ǂ and IL-6 are two pro-inflammatory cytokines that are involved as mediators of 
cancer associated cachexia. Similarly, an association has been postulated between elevated 
plasma levels of pro-inflammatory cytokines in AN and the manifestations of anorexia, 
cachexia and osteoporosis in these patients. These hypothesis conceive of cytokines as the 
fundamental regulators of body metabolism in AN and BN. However, it is evident that not 
all AN patients display the same changes in immune function and cytokine production 
(Nova & Marcos, 2006). A variable lymphocyte proliferative response to different mitogens 
has been reported in anorectic subjects (Polack et al., 1993). Different results for cytokine 
production by peripheral blood mononuclear cells (PBMCs) have also been reported. For 
instance, a higher spontaneous production of IL-1 by PBMCs has been reported in AN 
patients in comparison with a control group (Allende et al., 1998), while no differences were 
observed under similar conditions in other studies (Bessler et al., 1993; Vaisman et al., 1996). 
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Since complex interactions occur between cytokines and the central nervous system, 
differences in the capacity of AN patients to evoke a compensatory mechanism through 
either the neuroendocrine system or the autonomic nervous system could explain the 
variability of the results found (Nova et al., 2002). 
In fact, there is a study that shows specific adipocytokines profiles depending on the 
subtype of AN: restrictive versus binge/purge and hyperactive versus non-hyperactive 
forms. These biological signatures have been suggested to interfere with the outcome of the 
disease (Nogueira et al., 2010). The changes in neuropeptides and in the hypothalamic axis 
that mediate these changes also receive input from neuroendocrine signals sensitive to 
satiety and food intake and in turn may be poised to provide significant energy 
conservation. In fact, leptin is a key hormone in the regulation of food intake, energy 
expenditure, and neuroendocrine, and alters the immune function. Leptin is also related 
with obesity and its metabolic disorders; starvation-induced depletion of fat stores is 
accompanied by alterations of circulating adipocytokines that may have potential 
repercussions in the pathophysiology of AN. Adiponectin enhances insulin sensitivity, 
controls body weight, prevents atherosclerosis and negatively regulates immune functions. 
Plasma adiponectin relates inversely to adiposity and reflects the sequelae of accumulation 
of excess adiposity. Resistin is a protein hormone produced both by adipocytes and 
immunocompetent cells that affect fuel homeostasis and insulin action. Plasma resistin 
levels are decreased in AN, while plasma adiponectin levels are increased. Visfatin seems to 
correlate with visceral fat mass in patients with obesity. Its possible role in patients with AN 
is unknown (Leoni et al., 2010). Plasma ghrelin levels present opposite changes in obesity 
and AN, suggesting that ghrelin is a good marker of nutritional status. This molecule, 
increased in subjects with restrictive AN, is normalized after refeeding (Terashi et al., 2011). 
3. Obesity 
Obesity is characterized by the hypertrophy of the adipose tissue, which has its roots in a 
positive energy balance. It has been long regarded as a mere state of overnutrition –an 
esthetical issue rather than a real disease. However, obesity appears often linked to 
metabolic disturbances, like insulin resistance, type 2 diabetes, non-alcoholic fatty liver 
disease, or coronary events. The underlying cause of these relationships appears to be an 
inflammatory response initiating in adipose tissue. Indeed, obesity is a state of low-grade 
chronic systemic inflammation and is associated as well to an altered immune function 
(Table 2). 
3.1 Adipose tissue as an immune organ 
There are various histological and functional connections between adipose tissue and the 
immune system, starting with the fact that immune cells –mainly macrophages and 
lymphocytes- are normally found in the non-adipose fraction of the tissue (Caspar-Bauguil 
et al., 2005). In addition, white adipocytes have been suggested to share embryonic origin 
with immune cells, and characterization of adipose tissue-resident lymphocytes led to the 
notion that it was an ancestral immune organ (Caspar-Bauguil et al. 2005; Saely et al. 2010). 
Recently, immature hematopoietic cells have been found in adipose tissue, so that it has 
been proposed as a site for formation and maturation of immune cell precursors (Poglio et 
al. 2010). 
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Biomarker Source Alteration Reference 
Adiponectin Blood 
Decreased circulating 
values 
Arita et al. 1999, as cited in 
Tilg & Moschen 2006. 
Leptin Blood 
Increased circulating 
values 
Bulló et al. 2003, as cited in 
Trayhurn & Wood 2004 
M-CSFR  
Adipose tissue 
macrophages 
Increased gene expression 
(in mice) 
Weisberg et al. 2003 
CD68 
Adipose tissue 
macrophages 
Increased gene expression 
(in mice) 
Weisberg et al. 2003 
TNF-ǂ 
Adipose tissue 
macrophages, 
adipocytes 
Increased gene expression 
(in rodents and humans) 
Reviewed in Wellen & 
Hotamisligil 2005 
TNF-Rs Blood 
Increased circulating 
values 
Bulló et al. 2003, as cited in 
Trayhurn & Wood 2004 
IL-6 
Adipose tissue 
macrophages, 
adipocytes 
Increased gene expression 
(in mice) 
Reviewed in Wellen & 
Hotamisligil 2005 
IL-6 Blood 
Increased circulating 
values 
Bulló et al. 2003, as cited in 
Trayhurn & Wood 2004 
IL-8 
Adipose tissue 
macrophages, 
adipocytes 
Increased gene expression 
(in mice) 
Reviewed in Wellen & 
Hotamisligil 2005 
MCP-1 Adipocytes 
Increased gene expression 
(in mice) 
Reviewed in Wellen & 
Hotamisligil 2005 
CRP Adipocytes 
Increased gene expression 
(in mice) 
Reviewed in Wellen & 
Hotamisligil 2005 
CRP Blood 
Increased circulating 
values 
Wärnberg et al. 2006 
Bulló et al. 2003, as cited in 
Trayhurn & Wood 2004 
C3, C4 Blood 
Increased circulating 
values 
Wärnberg et al. 2006 
Table 2. Inflammation-related biomarkers known to be altered in obesity 
In the early 2000s, studies in mice showed that the adipose tissue of obese animals was more 
densely macrophage-infiltrated than that belonging to lean mice. Those macrophages 
appeared as crown-shaped aggregates, larger with increasing degrees of obesity, and similar 
to those observed in known inflammatory situations, like rheumatoid arthritis. This finding 
led to the idea that immune function could be impaired in obesity, and the formation of 
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macrophage aggregates could partially explain the related inflammatory state (Weisberg et 
al. 2003). Later, two different adipose tissue macrophage phenotypes have been described: 
the M1 or “classically activated”, which acts as pro-inflammatory, and the M2 or 
“alternatively activated”, which acts as anti-inflammatory. Obesity is associated with a 
phenotypic switch from M2 to M1 polarization (Lumeng et al. 2007). Furthermore, specific 
deletion of M1 macrophages may improve insulin sensitivity and reduce inflammatory 
markers (Patsouris et al., 2008, as cited in Nicholls et al., 2011), while absence of the M2 
phenotype has been associated with higher susceptibility to obesity, inflammation, and 
insulin resistance (Odegaard et al., 2007, as cited in Nicholls et al., 2011). 
3.2 Obesity, adipokines and cytokines 
Adipose tissue secretes a great number of bioactive molecules of different nature, 
collectively termed adipokines, many of which have immunomodulatory actions. This is the 
case for the two paradigmatic adipokines, leptin and adiponectin. Leptin, the first adipokine 
to be discovered, is known to regulate immune function on various levels: it can stimulate 
monocyte proliferation and differentiation into macrophages, modulate activation of natural 
killer lymphocytes, and induce the production of pro-inflammatory cytokines, such as TNF-
ǂ, IL-6, or IL-12 (Tilg & Moschen, 2006). Adiponectin, considered as an anti-inflammatory 
and insulin-sensitizing hormone, exerts opposite actions. It inhibits the phagocytic activity 
and production of TNF-ǂ in macrophages, the differentiation of monocyte precursors, the 
synthesis of endothelial adhesion molecules, and the formation of foam cells (Koerner et al., 
2005), and stimulates the release of anti-inflammatory interleukins, like IL-10 or IL-1ra (Tilg 
& Moschen, 2006). In obesity, circulating leptin levels are increased, in parallel with body fat 
mass; on the contrary, adiponectin concentrations correlate inversely with body weight. 
These changes may contribute to the onset and maintenance of the systemic inflammation 
present in obesity. 
Obese subjects also show elevated circulating levels of various inflammation-related 
molecules, like C-reactive protein (CRP), haptoglobin, TNF-ǂ, IL-6, or components of the 
complement system, and this event is linked to the concomitant development of insulin 
resistance, metabolic disorders, or the increased cardiovascular risk seen in obesity 
(Wärnberg et al. 2006; Hotamisligil 2006). The raise of inflammatory markers has its roots in 
the enlargement of body fat mass, and it is explained largely, but not completely, by the 
infiltrated macrophage-dependent production of cytokines and chemokines. Adipocytes 
and macrophages share certain phenotypic features, including the capacity to produce and 
release cytokines. Fat cells secrete, amongst others, TNF-ǂ, IL-6, monocyte chemotactic 
protein (MCP)-1, TGF-ǃ, or acute phase proteins (revised in Trayhurn & Wood, 2004). 
Consequently, dysfunction of adipose tissue plays a key role in the development of the 
obesity-associated systemic inflammation and related pathologies. 
Lifestyle-aimed interventions seem to be useful to improve the inflammatory condition in 
obese subjects. Environmental factors such as physical activity may counteract the 
consequences of excessive body fat. Cardiorespiratory fitness has been inversely associated 
with serum levels of inflammatory markers such as CRP and complement factors C3 and C4, 
all of which were positively associated with body fat (Martínez-Gómez et al., 2010). An 
intervention programme carried out on overweight/obese adolescents (aged 13-16 years) to 
promote a healthy lifestyle and lose weight (the EVASYON study), resulted in decreased 
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serum levels of leptin and several cytokines (IL-8, IL-10 and TNF-ǂ), without affecting those 
of adiponectin, total peptide YY, or even insulin, and these changes seemed to depend on 
physical activity and fitness (Romeo et al., 2011). 
3.3 Proposed mechanisms linking obesity and inflammation in adipose tissue 
3.3.1 Fatty acid-induced inflammation 
Abnormally elevated blood lipid levels, including free fatty acids, are a common feature 
in obesity. There are different explanations for this increase. One is known as the “adipose 
tissue expandability” hypothesis (Virtue & Vidal-Puig, 2010, as cited in Pietiläinen et al., 
2011). According to this hypothesis, the adipose tissue has a limited capacity to expand 
and to store energy. When this limit is exceeded, it leads to enhanced lipolysis within the 
adipocyte and the subsequent release of free fatty acids into the bloodstream, reaching 
other tissues and organs, in which they exert toxic effects –a phenomenon known as 
lipotoxicity. Other studies have demonstrated that inflammatory cytokines increase free 
fatty acid levels (Grunfeld & Feingold, 1991, as cited in Mei et al., 2011). Finally, recent 
observations suggest that chronic systemic inflammation stimulates lipolysis and 
decreases lipogenesis in adipose tissue, while increasing lipid synthesis in skeletal muscle 
and liver (Mei et al., 2011). 
The chemical nature of fatty acids is also relevant in triggering the inflammatory response. 
Studies with weight-discordant twins have shown that obese individuals, who exhibited 
signs of insulin resistance and elevated inflammatory and immune response pathways in 
the adipose tissue when compared to their lean twins, also showed significant differences in 
adipose tissue fatty acid composition (Pietiläinen et al., 2011). There seems to be a positive 
feedback loop involving saturated fatty acids (SFA) from adipocytes and cytokines from 
macrophages, which accelerates the inflammatory change in the adipose tissue in obesity. 
SFA can increase the production of TNF-ǂ in macrophages, and in turn the latter induce 
lipolysis in adipocytes (Suganami et al., 2007). 
Fatty acids have been suggested to modulate adipokine production and/or secretion. 
Likewise in macrophages, SFA may stimulate TNF-ǂ and IL-6 expression and release in 
adipocytes (reviewed in Stryjecki & Mutch, 2011). Adiponectin levels also seem to be 
associated with fatty acids, being this correlation negative with SFA, palmitoleic (16:1n7) 
or Ǆ-linolenic (18:3n6) fatty acids, and positive with oleic acid, or total n-6 and n-3 poly-
unsaturated fatty acids (PUFA) (Fernandez-Real et al., 2005; Pérez de Heredia et al., 
2009). 
Alternatively, fatty acids may directly elicit the inflammatory response, through activation 
of cell receptors. For instance, they are natural ligands for peroxisome proliferator-activated 
receptors (PPARs); these transcription factors, apart from regulating cell metabolism and 
adipocyte formation, can suppress the activity of the nuclear factor kappa B (NF-κB), a 
crucial transcription factor in the initiation of the inflammatory response, and they seem to 
be involved in the aforementioned phenotypic switch of adipose tissue-resident 
macrophages (reviewed in Coll et al., 2010). On the other hand, recent evidence has 
suggested that fatty acids, especially SFA, could also act through the toll-like receptors 
(TLRs), the activation of which induces the synthesis of inflammatory markers in 
macrophages and aggravates insulin resistance (Fessler et al., 2009, as cited in Stryjecki & 
Mutch 2011). 
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3.3.2 Endoplasmic reticulum stress 
The excessive adipose tissue growth has further consequences at the cellular and subcellular 
levels, and a role has been suggested for endoplasmic reticulum stress in the origin of 
adipocyte dysfunction in obesity. The endoplasmic reticulum (ER) is a primary site for 
protein synthesis and triglyceride droplet formation. Under conditions of cellular stress, ER 
function becomes progressively impaired and this triggers a security mechanism known as 
the “unfolded protein response” (UPR). The increased demand for protein and triglyceride 
droplet formation under nutrient excess and cell expansion in obesity may as well induce 
ER stress and the UPR. Additionally, nutrients themselves may serve as signals leading to 
ER stress; in relation to the previous section, free fatty acids have been shown to induce the 
UPR in various cell types. The UPR is linked to the production of reactive oxygen species 
(ROS) and the activation of inflammatory pathways, with increased expression of cytokines, 
including IL-8, IL-6, MCP-1, and TNF-ǂ. Paradoxically, glucose deprivation could contribute 
to ER stress in obesity; this could happen as a result of insulin resistance developing within 
the adipose tissue. Finally, closing a positive feed-back loop, the inflammatory condition in 
the obese adipose tissue induces the UPR and enhances ER stress (reviewed in Gregor & 
Hotamisligil, 2007). 
3.3.3 Hypoxia in adipose tissue 
The capacity of adipose tissue to change size surpasses that of other organs and tissues. 
Therefore, adipose tissue expansion in obesity eventually reaches a point where the 
development of local vasculature is insufficient and cannot meet the oxygen and nutrient 
demands of distant and enlarged adipocytes. It was hypothesized that hypoxic adipocytes 
would then produce inflammatory signals in order to stimulate angiogenesis, and later 
studies in animal and culture models have confirmed this hypothesis (reviewed in Trayhurn 
et al., 2010). The key element in the initiation of the cellular response to hypoxia is the 
hypoxia-inducible factor 1 (HIF-1), a transcription factor highly unstable under normal 
normoxic conditions, but which becomes stabilized when oxygen availability is low. Once 
stabilized, HIF-1 regulates the expression of a great number of genes involved in different 
functions that include angiogenesis, inflammation and energy metabolism; some of these 
genes are leptin, PAI-1 (plasminogen activator inhibitor 1), or MIF (macrophage migration 
inhibitory factor), which become up-regulated, or adiponectin, which becomes down-
regulated (Trayhurn et al., 2010). Hypoxia has in addition important consequences for 
adipocyte metabolism, as it forces the adipocyte to switch to anaerobic glycolysis to obtain 
energy from glucose. This results in increased production and release of lactate from 
adipocytes (Pérez de Heredia et al., 2010a). Lactate has been shown to stimulate 
inflammatory pathways in macrophages (Samuvel et al. 2009, as cited in Pérez de Heredia et 
al., 2010a) and seems to enhance lipopolysaccharide (LPS)-induced inflammatory response 
in preadipocytes (Pérez de Heredia et al., 2010b, as cited in Pérez de Heredia et al., 2010a). 
Other cell types present in adipose tissue are responsive to hypoxia, too. Resident 
macrophages accumulate around hypoxic areas, probably recruited by chemotactic 
signals released from adipocytes, and respond to hypoxia in a similar manner to 
adipocytes, by producing pro-inflammatory cytokines. Preadipocytes are also sensitive to 
the lack of oxygen, although their response is milder than that of mature adipocytes 
(Trayhurn et al., 2010). 
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It is apparent that the hypoxia response and HIF-1 activation fail to achieve the expected 
effect of increasing adipose tissue vascularization, but lead instead to a situation of local 
fibrosis which initiates adipose tissue dysfunction (Halberg et al., 2009, as cited in Trayhurn 
et al., 2010). In line with this, hypoxia has been found to induce the UPR in cultured 
adipocytes (Gregor & Hotamisligil, 2007). 
3.4 The influence of the adipose depot in obesity-related inflammation 
Most characteristics of adipose tissue vary according to its anatomical localization, and these 
differences make the visceral depots more clinically relevant than the subcutaneous depot, 
in relation to the development of metabolic disturbances, insulin resistance or 
cardiovascular risk. With regards to inflammation, there are several features that render 
visceral fat more detrimental than subcutaneous one. Firstly, adiponectin gene expression 
has been found to be lower in visceral than in subcutaneous adipose tissue (Hernández-
Morante et al., 2006). Secondly, infiltration of macrophages seems to be greater in visceral 
than in subcutaneous adipose tissue in obesity (Cancello et al., 2006, as cited in Villaret et al., 
2010). And more recently, it has been observed that, in obese subjects, endothelial cells 
isolated from visceral (omental) fat show a higher expression of genes related to 
angiogenesis and inflammation than endothelial cells from subcutaneous adipose tissue 
(Villaret et al., 2010). In addition, the expression of hypoxia-related genes seems to be 
greater in the visceral adipose tissue, even when it could not be attributed to poorer 
vascularization in this depot, as compared to the subcutaneous one. Moreover, the cells 
from visceral fat show more evident signs of cellular senescence than those from 
subcutaneous fat (Villaret et al., 2010). 
In conclusion, obesity-associated chronic systemic inflammation has its origin in adipose 
tissue dysfunction, and various plausible explanations have been proposed for the 
phenomenon, although more research is needed to confirm the precise mechanisms for 
adipose tissue inflammatory response. 
4. Celiac disease 
Celiac disease (CD) is defined as a permanent intolerance to gluten proteins of wheat, 
barley and rye. The only treatment for this chronic disease is a lifelong and strict gluten-
free diet (GFD) (Mujico et al., 2011). Although CD has been considered a primary 
gastrointestinal disease, this disease can affect other systemic organs, including the skin, 
blood (hematologic system) and bone. Recent evidence indicates that both innate and 
adaptive immune responses are necessary for the phenotypic expression and pathologic 
changes characteristic of CD (De Nitto et al., 2009). In genetically predisposed 
individuals, the adaptive response, mediated by the activation of antigen-specific T 
lymphocytes, drives a pro-inflammatory response, which ends in an immune-mediated 
enteropathy characterized by villous atrophy, crypt hyperplasia, recruitment of 
intraepithelial lymphocytes (IELs), and increase of numerous inflammation-related 
biomarkers (Table 3). In addition, some gluten peptides are able to induce an innate 
immune response in intestinal mucosa. There is evidence of a direct toxic effect of some 
gluten peptides in several biological models. However, the failure to control the 
inflammatory response may be one of the factors underlying gluten intolerance in these 
individuals (Garrote et al., 2008). 
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Biomarker Source Reference 
IFN-ǂ Intestinal mucosa cultures Monteleone et al., 2001, as cited in De Nitto et 
al., 2009 
IFN-Ǆ 
Intestinal mucosa cultures 
Nielsen et al., 1995 & 1998; as cited in De Nitto 
et al., 2009 
CD8+ ǂǃIELs Forsberg et al., 2007 
Seruma Manavalan et al., 2010 
IL-1ǂ Serumb Manavalan et al., 2010 
IL-1ǃ Serumb Manavalan et al., 2010 
IL-2 Seruma Manavalan et al., 2010 
IL-4 Seruma,b,c Manavalan et al., 2010 
IL-6 Serumc,d 
Manavalan et al., 2010 
Fornari et al., 1998; Romaldini et al., 2002; as 
cited in Manavalan et al., 2010 
IL-8 Serumb,c,e Manavalan et al., 2010 
IL-10 
CD4+ and CD8+ ǂǃIELs Forsberg et al., 2007 
Seruma,b 
Manavalan et al., 2010 
Cataldo et al., 2003, as cited in Manavalan et 
al., 2010 
IL-15 
Lamina propria and 
intestinal epitheliumc 
Di Sabatino et al., 2006 
Maiuri et al., 2000; Mention et al., 2003; as cited 
in De Nitto et al., 2009 
Lamina propria 
macrophages and dendritic 
cells 
Maiuri et al., 2003, as cited in De Nitto et al., 
2009 
IL-15Rǂ IELs Di Sabatino et al., 2006 
IL-18 
Crypts of intestinal mucosa 
cultures 
León et al., 2006 
IL-21 Intestinal mucosa cultures Fina et al., 2008, as cited in De Nitto et al., 2009 
TNF-ǂ CD4+ ǂǃIELs Forsberg et al., 2007 
Serum Manavalan et al., 2010 
Zonulin 
Intestinal tissue lysates Fasano et al., 2000, as cited in Visser et al., 2009 
Intestinal cell lines 
Clemente et al., 2003; Drago et al., 2006; as 
cited in Visser et al., 2009 
Serumd Fasano et al., 2000, as cited in Visser et al., 2009 
a Patients on GFD for less than 1 year had significantly higher levels of these biomarkers compared with 
the patients on GFD for more than 1 year. 
b Levels of these biomarkers correlated with the TTG IgA levels. 
c Levels of these biomarkers correlated with the degree of mucosal damage. 
d Levels of these biomarkers decreased following a GFD. 
e Levels of these biomarkers remained elevated despite a GFD and remained so even after a year of 
gluten exclusion. 
Table 3. Increased inflammation-related biomarkers in celiac disease 
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4.1 Link between gliadin, zonulin, and increased intestinal permeability in CD 
The intestinal epithelium is the largest mucosal surface and provides an interface between 
the external environment and the mammalian host. Healthy and mature gut mucosa with its 
intact tight junctions (TJ) serves as the main barrier to the passage of macromolecules (Visser 
et al., 2009). In a physiological state, quantitatively small but immunologically active 
antigens may cross the mucosal barrier. When the integrity of the gut barrier is 
compromised (TJ disassembly), an immune response to environmental antigens that crossed 
the gut mucosa may be developed, leading to autoimmune diseases or food allergies 
(Fasano, 2001b; Mowat, 2003; as cited in Visser et al., 2009). 
Several autoimmune diseases are characterized by loss of intestinal barrier function (Fasano, 
2001a, as cited in Visser et al., 2009). Quantitative immunoblotting of intestinal tissue lysates 
from active CD (ACD) patients confirmed the increase in zonulin protein (a human 
intestinal homolog of zonula occludens toxin, an enterotoxin that reversibly opens the TJ) 
compared to control tissues. The zonulin upregulation during the acute phase of CD was 
confirmed by measuring zonulin concentration in sera of 189 CD patients using a sandwich 
enzyme-linked immunosorbent assay (ELISA). Compared to healthy controls, CD subjects 
showed significantly higher zonulin serum concentrations during the acute phase of the 
disease that decreased following a GFD (Fasano et al., 2000, as cited in Visser et al., 2009). 
Intestinal cell lines exposed to gliadin released zonulin in the cell medium with subsequent 
zonulin binding to the cell surface, rearrangement of the cell cytoskeleton, loss of occludin-
ZO1 protein–protein interaction, and increased monolayer permeability. Pre-treatment with 
the zonulin antagonist AT1001 blocked these changes without affecting zonulin release. 
When exposed to luminal gliadin, intestinal biopsies from celiac patients in remission 
expressed a sustained luminal zonulin release and increase in intestinal permeability. 
Conversely, biopsies from non-CD patients demonstrated a limited, transient zonulin 
release, which was paralleled by a reduction in intestinal permeability that never reached 
the level of permeability seen in CD tissues. Interestingly, when gliadin was added to the 
basolateral side of either cell lines or intestinal biopsies, no zonulin release was detected 
(Clemente et al., 2003; Drago et al., 2006; as cited in Visser et al., 2009). It has been postulated 
that gliadin binds to the chemokine receptor CXCR3, expressed in human and mouse 
intestinal epithelium and lamina propria, and leads to activation of the zonulin pathway 
and increased intestinal permeability in a MyD88-dependent fashion (Lammers et al., 2008, 
as cited in Visser et al., 2009). 
4.2 The mucosal cytokine network involved in CD 
Although the pathogenesis of CD is not fully understood, it is known that gluten peptides 
are deamidated by tissue transglutaminase and presented by DQ2+ or DQ8+ antigen-
presenting cells to lamina propria CD4+ T cells (Di Sabatino & Corazza, 2009; Sjöström et al., 
1998; as cited in De Nitto et al., 2009). Upon activation, CD4+ T cells polarize along the T 
helper (Th)1-type pathway, as substantiated by their ability to produce large amounts of 
IFN-Ǆ, the signature cytokine of Th1 responses. In CD patients on a GFD, IFN-Ǆ production 
is as low as in healthy controls but it can be stimulated in vitro by gluten to reach levels of 
ACD patients. In these mucosal cultures, neutralization of IFN-Ǆ prevents gliadin-mediated 
morphological changes thus supporting the role of the adaptive immune response and IFN-
Ǆ in CD immunopathology (Nielsen et al., 1995 & 1998; as cited in De Nitto et al., 2009). 
ACD is also characterized by a prominent cytokine response of IELs to gluten-containing 
diet. CD8+ ǂǃIELs retrieved from small intestinal biopsies of children with ACD showed a 
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signiﬁcant increase in expression levels of both IFN-Ǆ and IL-10, the latter also increased in 
CD4+ ǂǃIELs. Production of IL-10 may be a common feature of IELs producing pro-
inﬂammatory cytokines, attempting to limit inﬂammation in an autocrine fashion (Forsberg 
et al., 2007). TNF-ǂ levels were increased in CD4+ ǂǃIELs, which also showed the highest 
expression level per cell and constituted the major source of this cytokine. Cytokine levels 
were low in ǄǅIELs (Forsberg et al., 2007). 
Some gluten peptides can induce mucosal damage by directly activating innate immune 
mechanisms. In particular, it was shown that the p31-43 peptide elicits the production of IL-
15 by lamina propria macrophages and dendritic cells in ex vivo organ cultures of CD 
biopsies, thus triggering a sequence of events that culminates in epithelial damage (Maiuri 
et al., 2003, as cited in De Nitto et al., 2009). These findings correlate well with the 
demonstration that IL-15 is over-expressed in both the lamina propria and intestinal 
epithelium of patients with ACD as compared with normal controls or GFD treated CD 
patients (Maiuri et al., 2000; Mention et al., 2003; as cited in De Nitto et al., 2009). The levels 
of IL-15 also correlate with the degree of mucosal damage (Di Sabatino et al., 2006). 
Epithelium derived IL-15, signalling via IL-15Rǂ, is critical for the development, activation, 
and survival of IELs. The IELs of ACD, characterised by higher IL-15Rǂ expression, showed 
increased proliferation, production of IFN-Ǆ and TNF-ǂ, and perforin/granzyme dependent 
cytotoxicity, and a decreased propensity to apoptosis in response to IL-15 (Di Sabatino et al., 
2006). These findings suggest that IL-15 plays a crucial role in the generation of epithelial 
damage in active CD. Blocking IL-15, by suppressing uncontrolled IEL activation and 
survival, has the potential to provide new therapeutic tools to prevent tissue damage and 
lymphomagenesis in CD (Di Sabatino et al., 2006). 
Biopsies taken from CD patients on a GFD over-expressed IL-21 when challenged in vitro 
with gluten peptides. Interestingly, neutralization of IL-21 activity in ex vivo organ cultures 
of CD biopsies reduced IFN-Ǆ production (Fina et al., 2008, as cited in De Nitto et al., 2009). 
IFN-ǂ, which is up-regulated in the mucosa of active CD patients and contributes to 
intensifying IFN-Ǆ production, enhanced the mRNA expression of IL-21 in activated human 
T cells, thus suggesting a role for IFN-ǂ in the positive control of IL-21 in CD (Monteleone et 
al., 2001; Strengell et al., 2004; as cited in De Nitto et al., 2009). It is tempting to speculate that 
IL-21 is part of a positive feedback loop that helps amplify and stabilize the committed Th1 
cell phenotype in CD (De Nitto et al., 2009). 
Both the active and inactive forms of IL-18 protein have been found in all samples from 
ACD, and protein expression was only localized within the crypts (León et al., 2006). In 
ACD, the early response following gluten intake characterized by high IFN-Ǆ levels is 
driven by IL-18, and probably IL-15, and this alternates with periods of long-standing 
inﬂammation with moderate IFN-Ǆ levels, maintained by IL-18 alone (León et al., 2006). 
All these observations collectively underline the complexity of the pathogenic mechanism in 
CD and suggest that the CD-associated mucosal damage relies on the activation of multiple 
rather than single cell pathways (De Nitto et al., 2009). 
4.3 Serum cytokine levels in CD 
Since the identification of tissue transglutaminase (TTG) as the autoantigen of CD, detection 
of anti-TTG IgA antibodies in the serum of CD patients has become an essential tool for the 
diagnosis of this disorder. Patients with ACD and those on a GFD with positive TTG IgA 
antibodies had significantly higher serum levels of pro-inflammatory cytokines, such as 
IFN-Ǆ, IL-1ǃ, TNF-ǂ, IL-6 and IL-8, and also Th2 cytokines such as IL-4 and IL-10, compared 
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with normal controls and patients on GFD without antibodies (Manavalan et al., 2010). 
There are also data documenting elevated serum levels of IL-10 in CD patients with 
underlying IgA deficiency (Cataldo et al., 2003, as cited in Manavalan et al., 2010) and high 
serum levels of IFN-Ǆ in other autoimmune diseases, some of which are associated with CD 
(Stepniak & Koning, 2006, as cited in Manavalan et al., 2010). 
Patients on GFD for less than 1 year had significantly higher levels of both pro-
inflammatory cytokines (IL-2 and IFN-Ǆ) and Th2 cytokines (IL-4 and IL-10) compared with 
the patients on GFD for more than 1 year (Manavalan et al., 2010). In other studies, serum 
IL-6 levels have been also found to be significantly increased in patients with ACD 
compared with controls, and decreased after following GFD for one year (Fornari et al., 
1998; Romaldini et al., 2002; as cited in Manavalan et al., 2010). Only serum IL-8 levels 
remained elevated despite a GFD and remained so even after a year of gluten exclusion 
(Manavalan et al., 2010). It was in contrast to what has been described in patients with 
dermatitis herpertiformis, in whom serum IL-8 levels returned to normal levels within 2 
years on a GFD (Hall et al., 2007, as cited in Manavalan et al., 2010). 
In addition, a statistically significant correlation between levels of TTG IgA titers and serum 
levels of Th2 cytokines IL-4, IL-10 and inflammatory cytokines such as IL-1, IL-1, and IL-8 
was observed. Moreover, using linear regression analysis, serum levels of IL-4, IL-6 and IL-8 
were found to correlate with the degree of villous atrophy (Manavalan et al., 2010). Higher 
levels of serum cytokines in patients with severe degrees of villous atrophy suggest a link 
between local mucosal alterations and systemic immune activation in this disease. 
These results suggest that patients with CD have high levels of circulating pro- and anti-
inflammatory cytokines, especially during the active phase of the disease, and differ from 
those of otherwise healthy individuals. Interestingly, most of these cytokines decrease when 
the patients commence a GFD; however a few cytokines that have been involved in the 
pathogenesis of tissue damage in CD, such as IFN-Ǆ, persist in the circulation despite GFD. 
Therefore, the serum cytokine profile does not seem to mirror the cytokine profile of the 
inflamed small intestinal mucosa of ACD patients. Cytokine elevations have also been 
reported in other diseases or disorders frequently associated with CD, including 
autoimmune thyroiditis, diabetes, hepatitis, osteopenia, as well as psychiatric 
manifestations, especially depression. It is likely that elevated levels of certain serum 
cytokines might underlie extraintestinal manifestations of CD (Manavalan et al., 2010). 
5. Conclusion 
In this chapter we have discussed three paradigmatic cases of malnutrition that have a 
strong immune and inflammatory impact: anorexia nervosa (AN) and bulimia nervosa (BN), 
obesity, and celiac disease (CD). These patients have dysregulated levels of various 
inflammation-related molecules, especially during the active phase of the disease, and differ 
from those of otherwise healthy individuals. It is likely that these alterations might 
contribute to the onset and maintenance of the systemic inflammation. The failure to control 
the inflammatory response may be one of the factors underlying forthcoming complications 
and concomitant development of other diseases or disorders, including autoimmune 
thyroiditis, diabetes, hepatitis, osteopenia, psychiatric manifestations (especially 
depression), as well as some types of cancer. Consequently, malnutrition plays a key role in 
the development of associated systemic inflammation and related pathologies. All these 
observations collectively underline the complexity of the pathogenic mechanisms of these 
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diseases and suggest that the damage relies on the activation of multiple rather than single 
cell pathways. 
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